Italian Angels for Growth — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Lever Bioleverbio.cominDec 2025
Lever Bio develops immunotherapy drug candidates in immuno-oncology, partnering with top researchers and academic institutions to translate discoveries into cancer immunotherapies.
BiotechDeep TechHealthtechMedical Devices
Pietro Puglisi(Chief Executive Officer)in
Co-investorsClaris VenturesExor VenturesClub degli InvestitoriOra Global
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.